Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified
Conditions
Interventions
Intervention1: Linga Chendooram: 65 mg twice daily with honey
Oral route
duration : 45 days
Sponsors
NIL
Eligibility
Inclusion criteria
Inclusion criteria: Onset of arthritis after the age of 16 years Positive for rheumatoid factor (RF) Anti - CCP Either an erythrocyte sedimentation rate (ESR) of greater than 30 mm/hr OR C-reactive protein level greater than 1.0 mg/dl (normal less than 0.4) Diagnosis of Uthira Vatha Suronitham, as defined by fulfilling at least more than two articular involvements Minor Morning stiffness Willing to take study medication Willing to follow diet restriction Patients giving informed consent (Signed or oral witnessed, according to local regulations) before any Protocol specific procedures.
Exclusion criteria
Exclusion criteria: Uncontrolled Diabetes Mellitus Uncontrolled Hypertension Cardiac disease Renal disease Neurological disorders Pregnancy and lactation History of alcohol or substance abuse Active infection, or chronic or persistent infection that might worsen with immunosuppressive treatment Patients who have already participated in a new drug study in the past 3 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction of pain and swelling of the jointsTimepoint: Baseline and 12 th week | — |
Secondary
| Measure | Time frame |
|---|---|
| To study the clinical laboratory parameters related to RA RA Factor CRP ESR etcTimepoint: Baseline ad 12th wek | — |
Countries
India
Contacts
Public ContactDr Janani Syamaroopa Jnanathapaswini
National Institute of Siddha,Tambaram,Chennai
Outcome results
None listed